Sharp plans to expand its secondary packaging facility in Pennsylvania

Sharp plans to expand its secondary packaging facility in Pennsylvania

Sharp Services, a provider of contract packaging and clinical delivery services, has announced an expansion of its Macungie facility in Pennsylvania, US.

This development aims to strengthen the company’s production capacity for secondary sterile injectable packaging, in response to increasing market demand.

Located in the heart of the US East Coast biopharmaceutical community, the Macungie location is currently equipped to offer pharmaceutical primary and secondary packaging services.

Sharp expects the expansion to increase secondary packaging capabilities, including vial labeling, auto-injector/pen assembly and labeling, injectable drug packaging and prefilled syringe assembly and labeling.

These services are aimed at pharmaceutical and biotech companies looking for reliable packaging solutions.

Sharp CCO Jeff Benedict said: “Demand for sterile injectable medicines has soared in recent years due to increased investment in the biologics industry across all therapeutic categories, therapies for rare and orphan diseases, and blockbuster GLP-1 agonists.”

Gain access to the most comprehensive company profiles on the market, powered by GlobalData. Save hours of research. Gain competitive advantage.

Company Profile – Free Sample

Your download email will arrive shortly

We have confidence in the unique quality of our company profiles. However, we want you to make the most beneficial decision for your business. That’s why we offer you a free sample that you can download by submitting the form below.

By GlobalData

Please visit our Privacy Policy to learn more about our services, how we may use, process and share your personal data, including information about your rights in relation to your personal data and how to unsubscribe from future marketing communications. Our services are intended for business subscribers and you warrant that the email address provided is your business email address.

The expansion of the Macungie location will create an additional 157,500 ft² of space, resulting in a total surface area of ​​315,000 ft². This will bring Sharp’s global footprint to over 1.7 million square meters.

Kevin Orfan, CEO of Sharp, said: “With this expansion, the Macungie site will double in size, allowing Sharp to provide additional capacity and capabilities to our biopharmaceutical customers for complex biologics and small molecule injectables.”

The expansion plan includes the construction and fit-out of new packaging suites, cold storage areas and surrounding warehouse space.

It also includes the installation of equipment and technology to support the assembly, labeling and packaging of injectables.

Orfan added: “Once the GMP (good manufacturing practice) infrastructure is in place, we expect 75 to 100 colleagues to be added to the Sharp team.”

Sharp Services recently commissioned a new 660-pallet cold storage facility, where temperatures are maintained between 2 and 8°C.